MHRA Drug Safety Update July 2022
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 12 July 2022) has been published and includes articles on: Topiramate (Topamax): start of safety review triggered by a study reporting an increased risk of neurodevelopmental disabilities in children with prenatal exposure COVID-19 vaccines and medicines: updates for July 2022 [...]
The post MHRA Drug Safety Update July 2022 appeared first on PSNC Website.
Recent Comments